Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Novo Nordisk A/S (NYSE:NVO)

55.73
Delayed Data
As of Aug 28
 -0.43 / -0.77%
Today’s Change
41.72
Today|||52-Week Range
60.34
+31.69%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Quarter
Trend
Quarter 3
2014
Quarter 4
2014
Quarter 1
2015
Quarter 2
2015
Revenue and IncomeNet Revenues3.9B4.1B3.7B4.0B
 
 
 
 
 
Cost of Goods Sold472.2M589.9M477.0M477.9M
 
 
 
 
 
Depreciation And Amortization128.5M74.4M98.5M96.4M
 
 
 
 
 
 
Operating ExpensesGross Income3.3B3.4B3.2B3.5B
 
 
 
 
 
General Expenses1.8B1.9B1.5B1.7B
 
 
 
 
 
Research And Development640.7M642.1M482.8M451.7M
 
 
 
 
 
Total Operating Expenses2.4B2.6B2.1B2.2B
 
 
 
 
 
 
Non-Operating ExpensesOperating Income1.5B1.5B1.6B1.8B
 
 
 
 
 
Extraordinary Credit--0.00353.0M--
 
 
Extraordinary Charge---79.7M----
 
 
Interest Expense On Debt77.3M--246.1M254.0M
 
 
 
 
Other Expenses86.8M-23.8M102.6M22.6M
 
 
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income1.5B1.4B1.9B1.6B
 
 
 
 
 
Income Taxes-342.6M---387.6M-328.1M
 
 
 
 
Net Income1.1B1.1B1.5B1.2B
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS2.6B2.6B2.6B2.6B
 
 
 
 
 
Shares To Calculate EPS Diluted2.6B2.6B2.6B2.6B
 
 
 
 
 
 
Earnings Per ShareEPS$0.44$0.42$0.56$0.48
 
 
 
 
 
EPS Diluted$0.43$0.42$0.56$0.48